OxiGene (OXGN)

Add to Watchlists
Create an Alert
1.53 -0.02  -1.29% NASDAQ Apr 20, 8:00PM BATS Real time Currency in USD
View Full Chart
OXGN Price Chart
View All Events

OXGN Events

Date Type Description
04/15/2015 15:00 EDT Misc OXIGENE ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR AND MEDICAL CONFERENCES
03/17/2015 16:30 EDT Misc OxiGene Inc Fourth Quarter Earnings Conference Call in 2014
03/17/2015 Earnings OxiGene Inc Fourth Quarter Earnings in 2014 Release
11/12/2014 16:30 EDT Misc OxiGene Announces Third Quarter 2014 Earnings Conference Call and Webcast
11/12/2014 Earnings OXIGENE ANNOUNCES THIRD QUARTER 2014 EARNINGS RELEASE
08/05/2014 16:30 EDT Misc OxiGene Inc Q2 2014 Earnings Conference Call
08/05/2014 Earnings OxiGene Inc Q2 2014 Earnings Results
06/10/2014 Misc Annual General Meeting for OxiGene Inc
05/06/2014 16:30 EDT Misc OxiGene Inc Q1 2014 Earnings Conference Call
05/06/2014 Earnings OxiGene Inc Q1 2014 Earnings Results
View All Performance Charts

OXGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OxiGene is down 45.71% over the last year vs S&P 500 Total Return up 14.94%, Oncothyreon down 29.92%, and Biodel down 54.20%.

Get Quote for
Advertisement

Portfolio Strategies Featuring OXGN

Did OxiGene make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OXGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.oxigene.com
  • IR Website: http://investor.oxigene.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

OxiGene Inc is a biopharmaceutical company. The Company is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer. It has two clinical stage product candidates that are developed in three potential oncology indications.

OXGN Excel Add-In Codes

  • Name: =YCI("OXGN","name")
  • Description: =YCI("OXGN","description")
  • Sector: =YCI("OXGN","sector")
  • Industry: =YCI("OXGN","industry")
  • Est. Current Fiscal Year End: =YCI("OXGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.